Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: A comparative study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 5, 2012, Pages 669-677

  Ejstrup, Rasmus ^a   La Cour, M ^a   Heegaard, S ^a   Kiilgaard, J F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BBG; Brilliant Blue G; Chromovitrectomy; Dye assisted ILM staining; ICG; ILM peeling; ILM staining; Indocyanine green; Kenalog; mfERG; Multifocal electroretinography; Pig; Retinal toxicity; Retinotoxicity; TA; Triamcinolone acetonide

Indexed keywords

BRILLIANT BLUE; CHLORAMPHENICOL; INDOCYANINE GREEN; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD RETINA BARRIER; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA; RETINA MACULA HOLE; SWINE; VITRECTOMY;

ANIMALS; APOPTOSIS; BLOOD-RETINAL BARRIER; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; INDOCYANINE GREEN; MODELS, ANIMAL; OPHTHALMOSCOPY; RETINA; ROSANILINE DYES; SUS SCROFA; TRIAMCINOLONE ACETONIDE; VITRECTOMY;

EID: 84862888627     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1886-3     Document Type: Article

References (56)

1. Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107: 2010-2014
2. Farah ME, Maia M, Rodrigues EB (2009) Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 148: 332-340
3. Stanescu-Segall D, Jackson TL (2009) Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye 23: 504-518
4. Kiilgaard JF, Nissen MH, la Cour M (2006) An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 84: 42-46
5. Hirata A, Inomata Y, Kawaji T, Tanihara H (2003) Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy. Am J Ophthalmol 136: 353-355
6. Czajka MP, McCuen BW, Cummings TJ, Nguyen H, Stinnett S, Wong F (2004) Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 24: 275-282
7. Beutel J, Dahmen G, Ziegler A, Hoerauf H (2007) Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 125: 326-332
8. Christensen UC, Kroyer K, Sander B, Larsen M, Henning V, Villumsen J, la Cour M (2009) Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol 93: 1005-1015
9. Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG (2007) Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245: 973-979
10. Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T (2006) Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 26: 623-630
11. Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T (2006) Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 26: 631-636
12. Remy M, Thaler S, Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Gruterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C (2008) An in vivo evaluation of brilliant blue G in animals and humans. Br J Ophthalmol 92: 1142-1147
13. Enaida H, Ishibashi T (2008) Brilliant blue in vitreoretinal surgery. Dev Ophthalmol 42: 115-125
14. Maia M, Farah ME, Rodrigues EB, Malerbi FK (2009) Subretinal brilliant blue G migration during internal limiting membrane peeling. Br J Ophthalmol 93: 1687
15. Ueno A, Hisatomi T, Enaida H, Kagimoto T, Mochizuki Y, Goto Y, Kubota T, Hata Y, Ishibashi T (2007) Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 27: 499-504
16. Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M (2005) Triamcinolone-assisted internal limiting membrane peeling. Retina 25: 972-975
17. Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47: 722-728
18. Yu SY, Damico FM, Viola F, D'Amico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26: 531-536
19. Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84: 342-348
20. Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, Takasu I, Ohtsuki H (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 28: 427-432
21. Kyhn MV, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2008) Functional implications of short-term retinal detachment in porcine eyes: study by multifocal electroretinography. Acta Ophthalmol (Oxf) 86: 18-25
22. Ejstrup R, Kiilgaard JF, Tucker BA, Klassen HJ, Young MJ, la Cour M (2010) Pharmacokinetics of intravitreal glial cell linederived neurotrophic factor: experimental studies in pigs. Exp Eye Res 91: 890-895
23. Ejstrup R, Scherfig E, la Cour M (2011) Electrophysiological consequences of experimental branch retinal vein occlusion in pigs and the effect of dorzolamide. Invest Ophthalmol Vis Sci 52: 952-958
24. Kyhn MV, Warfvinge K, Scherfig E, Kiilgaard JF, Prause JU, Klassen H, Young M, la Cour M (2009) Acute retinal ischemia caused by controlled low ocular perfusion pressure in a porcine model. Electrophysiological and histological characterisation. Exp Eye Res 88: 1100-1106
25. Saikia P, Maisch T, Kobuch K, Jackson TL, Baumler W, Szeimies RM, Gabel VP, Hillenkamp J (2006) Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 47: 4998-5003
26. Ferencz M, Somfai GM, Farkas A, Kovacs I, Lesch B, Recsan Z, Nemes J, Salacz G (2006) Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 142: 765-770
27. Horio N, Horiguchi M (2004) Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 122: 992-996
28. Kawaji T, Hirata A, Inomata Y, Koga T, Tanihara H (2004) Morphological damage in rabbit retina caused by subretinal injection of indocyanine green. Graefes Arch Clin Exp Ophthalmol 242: 158-164
29. Penha FM, Maia M, Farah ME, Dib E, Principe AH, Devin F, Rodrigues EB, Duprat JP, Freymuller E (2008) Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits. J Ocul Pharmacol Ther 24: 52-61
30. Penha FM, Maia M, Eid FM, Principe AH, Freymuller EH, Maia A, Magalhaes O Jr, Smith RL (2007) Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 114: 899-908
31. Maia M, Kellner L, de Juan E Jr, Smith R, Farah ME, Margalit E, Lakhanpal RR, Grebe L, Au Eong KG, Humayun MS (2004) Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 24: 80-91
32. Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY (2003) Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina 23: 675-681
33. Sato Y, Tomita H, Sugano E, Isago H, Yoshida M, Tamai M (2006) Evaluation of indocyanine green toxicity to rat retinas. Ophthalmologica 220: 153-158
34. Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, Au Eong KG, Farah ME, Fujii GY, Weiland J, de Juan E Jr, D'Anna SA, Humayun MS (2004) Effects of intravitreal indocyanine green injection in rabbits. Retina 24: 69-79
35. Goldstein M, Zemel E, Loewenstein A, Perlman I (2006) Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 47: 2100-2107
36. Creuzot-Garcher C, Acar N, Passemard M, Bidot S, Bron A, Bretillon L (2010) Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina. Retina 30: 1294-1301
37. Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME (2007) Vital dyes for chromovitrectomy. Curr Opin Ophthalmol 18: 179-187
38. Rodrigues EB, Penha FM, Farah ME, de Paula F, Costa E, Maia M, Dib E, Bottos J, Freymuller E, Furlani B, Meyer CH, Magalhaes O Jr, Lima-Filho AA, Safatle A (2009) Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 29: 497-510
39. Luke M, Januschowski K, Beutel J, Luke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P (2008) Electrophysiological effects of brilliant blue G in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Exp Ophthalmol 246: 817-822
40. Ueno A, Enaida H, Hata Y, Hisatomi T, Nakamura T, Mochizuki Y, Sakamoto T, Ishibashi T (2007) Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study. Eur J Ophthalmol 17: 392-398
41. Haritoglou C, Yu A, Freyer W, Priglinger SG, Alge C, Eibl K, May CA, Welge-Luessen U, Kampik A (2005) An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 46: 3315-3322
42. Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K (2007) Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 38: 365-370
43. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA (2005) Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112: 593-598
44. Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, Yokoyama M, Furukawa M, Sonoda Y, Yamada T, Doi N, Enaida H, Hata Y, Ishibashi T (2007) Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 114: 289-296
45. Tadayoni R, Paques M, Girmens JF, Massin P, Gaudric A (2003) Persistence of fundus fluorescence after use of indocyanine green for macular surgery. Ophthalmology 110: 604-608
46. Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y (2003) Retention of dye after indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 136: 172-174
47. Engel E, Schraml R, Maisch T, Kobuch K, Konig B, Szeimies RM, Hillenkamp J, Baumler W, Vasold R (2008) Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci 49: 1777-1783
48. Schmidt LC, Steffansen B, Scherfig E, la Cour M (2005) Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs. Acta Ophthalmol Scand 83: 184-190
49. Simoens P, De Schaepdrijver L, Lauwers H (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. A: morphology of the retinal microvasculature. Exp Eye Res 54: 965-973
50. De Schaepdrijver SL, Simoens P, Pollet L, Lauwers H, De Laey JJ (1992) Morphologic and clinical study of the retinal circulation in the miniature pig. B: fluorescein angiography of the retina. Exp Eye Res 54: 975-985
51. Chandler MJ, Smith PJ, Samuelson DA, MacKay EO (1999) Photoreceptor density of the domestic pig retina. Vet Ophthalmol 2: 179-184
52. Wang M, Sander B, la Courla M, LarsenM (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83: 691-696
53. Immel J, Negi A, Marmor MF (1986) Acute changes in RPE apical morphology after retinal detachment in rabbit. A SEM study. Invest Ophthalmol Vis Sci 27: 1770-1776
54. Voss KM, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2007) The multifocal electroretinogram (mfERG) in the pig. Acta Ophthalmol Scand 85: 438-444
55. Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43: 1673-1685
56. Ng YF, Chan HH, Chu PH, Siu AW, To CH, Beale BA, Gilger BC, Wong F (2008) Pharmacologically defined components of the normal porcine multifocal ERG. Doc Ophthalmol 116: 165-176